Acute Myeloid Leukemia Plasma | High-Quality Human Plasma from Acute Myeloid Leukemia (AML) Donors

Acute Myeloid Leukemia Plasma is collected from donors clinically diagnosed with acute myeloid leukemia (AML) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human AML plasma supports research focused on biomarker discovery and monitoring, and treatment development for AML.

Product Features

• Research Use Only (RUO)
• AML plasma collected from clinically confirmed donors
• Processed within one day of collection
• IRB-approved protocols and informed consent
• Custom aliquot volumes available upon request

Donor Metadata

• Verified AML diagnosis
• Demographic data: age, sex assigned at birth, race/ethnicity
• Donor-reported medications, allergies, and comorbidities
• Additional AML-specific metadata available

Applications

• Biomarker discovery and validation
• Cytokine and inflammation profiling
• Metabolomics and proteomics studies
• Therapeutic response research

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Acute Myeloid Leukemia plasma is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.